{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T17:33:16Z","timestamp":1790875996467,"version":"4.1.0"},"reference-count":47,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2011,8,1]],"date-time":"2011-08-01T00:00:00Z","timestamp":1312156800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Immunology Letters"],"published-print":{"date-parts":[[2011,8]]},"DOI":"10.1016\/j.imlet.2011.04.004","type":"journal-article","created":{"date-parts":[[2011,4,19]],"date-time":"2011-04-19T17:13:42Z","timestamp":1303233222000},"page":"161-168","source":"Crossref","is-referenced-by-count":14,"title":["Selective elimination of pathogenic synovial fluid T-cells from Rheumatoid Arthritis and Juvenile Idiopathic Arthritis by targeted activation of Fas-apoptotic signaling"],"prefix":"10.1016","volume":"138","author":[{"given":"Edwin","family":"Bremer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wayel H.","family":"Abdulahad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"de Bruyn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douwe F.","family":"Samplonius","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cees G.M.","family":"Kallenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wineke","family":"Armbrust","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Brouwers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harald","family":"Wajant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wijnand","family":"Helfrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.imlet.2011.04.004_bib0005","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/ar1478","article-title":"The role of T-cell interleukin-17 in conducting destructive arthritis: lessons from animal models","volume":"7","author":"Lubberts","year":"2005","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.imlet.2011.04.004_bib0010","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s00281-009-0189-9","article-title":"Th17 cytokines and arthritis","volume":"32","author":"Lubberts","year":"2010","journal-title":"Semin Immunopathol"},{"key":"10.1016\/j.imlet.2011.04.004_bib0015","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1002\/art.1780381109","article-title":"Double-blind, placebo-controlled multicenter trial using chimeric monoclonal anti-CD4 antibody, cM-T412, in rheumatoid arthritis patients receiving concomitant methotrexate","volume":"38","author":"Moreland","year":"1995","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.imlet.2011.04.004_bib0020","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1111\/j.1365-3083.1992.tb03102.x","article-title":"Treatment of rheumatoid arthritis with single dose or weekly pulses of chimaeric anti-CD4 monoclonal antibody","volume":"36","author":"Choy","year":"1992","journal-title":"Scand J Immunol"},{"key":"10.1016\/j.imlet.2011.04.004_bib0025","first-page":"1348","article-title":"Chimeric CD7 monoclonal antibody therapy in rheumatoid arthritis","volume":"19","author":"Kirkham","year":"1992","journal-title":"J Rheumatol"},{"key":"10.1016\/j.imlet.2011.04.004_bib0030","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1136\/ard.2007.080002","article-title":"Efficacy and safety of abatacept or infliximab vs placebo in ATTEST: a phase III, multi-centre, randomised, double-blind, placebo-controlled study in patients with rheumatoid arthritis and an inadequate response to methotrexate","volume":"67","author":"Schiff","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.imlet.2011.04.004_bib0035","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1038\/nm.1984","article-title":"Targeted depletion of lymphotoxin-[alpha]-expressing TH1 and TH17 cells inhibits autoimmune disease","volume":"15","author":"Chiang","year":"2009","journal-title":"Nat Med"},{"key":"10.1016\/j.imlet.2011.04.004_bib0040","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1038\/373438a0","article-title":"Autocrine T-cell suicide mediated by APO-1\/(Fas\/CD95)","volume":"373","author":"Dhein","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.imlet.2011.04.004_bib0045","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1038\/373441a0","article-title":"Cell-autonomous Fas (CD95)\/Fas-ligand interaction mediates activation-induced apoptosis in T-cell hybridomas","volume":"373","author":"Brunner","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.imlet.2011.04.004_bib0050","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1172\/JCI119178","article-title":"Inhibition of T cell apoptosis in the rheumatoid synovium","volume":"99","author":"Salmon","year":"1997","journal-title":"J Clin Invest"},{"key":"10.1016\/j.imlet.2011.04.004_bib0055","first-page":"1332","article-title":"Novel mechanisms of selective apoptosis in synovial T cells of patients with rheumatoid arthritis","volume":"23","author":"Hoa","year":"1996","journal-title":"J Rheumatol"},{"key":"10.1016\/j.imlet.2011.04.004_bib0060","first-page":"1609","article-title":"Antirheumatic effects of humanized anti-Fas monoclonal antibody in human rheumatoid arthritis\/SCID mouse chimera","volume":"29","author":"Matsuno","year":"2002","journal-title":"J Rheumatol"},{"key":"10.1016\/j.imlet.2011.04.004_bib0065","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.clim.2004.03.011","article-title":"Fas ligand-dependent suppression of autoimmunity via recruitment and subsequent termination of activated T cells","volume":"112","author":"Modiano","year":"2004","journal-title":"Clin Immunol"},{"key":"10.1016\/j.imlet.2011.04.004_bib0070","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1093\/rheumatology\/kei113","article-title":"Fas (CD95)-related apoptosis and rheumatoid arthritis","volume":"45","author":"Peng","year":"2006","journal-title":"Rheumatology"},{"key":"10.1016\/j.imlet.2011.04.004_bib0075","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/nm0198-031","article-title":"Downregulation of Fas ligand by shedding","volume":"4","author":"Tanaka","year":"1998","journal-title":"Nat Med"},{"key":"10.1016\/j.imlet.2011.04.004_bib0080","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1084\/jem.187.8.1205","article-title":"Conversion of membrane-bound Fas(CD95) ligand to its soluble form is associated with downregulation of its proapoptotic activity and loss of liver toxicity","volume":"187","author":"Schneider","year":"1998","journal-title":"J Exp Med"},{"key":"10.1016\/j.imlet.2011.04.004_bib0085","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1084\/jem.186.12.2045","article-title":"Membrane Fas ligand kills human peripheral blood T lymphocytes, and soluble fas ligand blocks the killing","volume":"186","author":"Suda","year":"1997","journal-title":"J Exp Med"},{"key":"10.1016\/j.imlet.2011.04.004_bib0090","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1002\/1529-0131(199804)41:4<657::AID-ART12>3.0.CO;2-N","article-title":"Soluble Fas ligand in the joints of patients with rheumatoid arthritis and osteoarthritis","volume":"41","author":"Hashimoto","year":"1998","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.imlet.2011.04.004_bib0095","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1128\/MCB.23.4.1428-1440.2003","article-title":"Two adjacent trimeric Fas ligands are required for Fas signaling and formation of a death-inducing signaling complex","volume":"23","author":"Holler","year":"2003","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.imlet.2011.04.004_bib0100","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.leukres.2005.08.006","article-title":"A Fas agonist induces high levels of apoptosis in haematological malignancies","volume":"30","author":"Greaney","year":"2006","journal-title":"Leuk Res"},{"key":"10.1016\/j.imlet.2011.04.004_bib0105","doi-asserted-by":"crossref","first-page":"32077","DOI":"10.1074\/jbc.M304866200","article-title":"Generation of a FasL-based proapoptotic fusion protein devoid of systemic toxicity due to cell-surface antigen-restricted activation","volume":"278","author":"Samel","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.imlet.2011.04.004_bib0110","doi-asserted-by":"crossref","first-page":"2863","DOI":"10.1182\/blood-2005-07-2929","article-title":"CD7-restricted activation of Fas-mediated apoptosis: a novel therapeutic approach for acute T-cell leukemia","volume":"107","author":"Bremer","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.imlet.2011.04.004_bib0115","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1158\/0008-5472.CAN-07-5171","article-title":"Superior activity of fusion protein scFvRit:sFasL over cotreatment with rituximab and Fas agonists","volume":"68","author":"Bremer","year":"2008","journal-title":"Cancer Res"},{"key":"10.1016\/j.imlet.2011.04.004_bib0120","doi-asserted-by":"crossref","first-page":"3380","DOI":"10.1158\/0008-5472.CAN-04-2756","article-title":"Target cell restricted apoptosis induction of acute leukemic T cells by a recombinant tumor necrosis factor-related apoptosis-inducing ligand fusion protein with specificity for human CD7","volume":"65","author":"Bremer","year":"2005","journal-title":"Cancer Res"},{"key":"10.1016\/j.imlet.2011.04.004_bib0125","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.4049\/jimmunol.0802597","article-title":"Trimer stabilization, oligomerization, and antibody-mediated cell surface immobilization improve the activity of soluble trimers of CD27L, CD40L, 41BBL, and glucocorticoid-induced TNF receptor ligand","volume":"183","author":"Wyzgol","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.imlet.2011.04.004_bib0130","doi-asserted-by":"crossref","first-page":"2830","DOI":"10.1002\/art.24747","article-title":"Urinary CD4+ effector memory T cells reflect renal disease activity in antineutrophil cytoplasmic antibody-associated vasculitis","volume":"60","author":"Abdulahad","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.imlet.2011.04.004_bib0135","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.clim.2006.07.007","article-title":"Rheumatoid synovial fluid T cells are sensitive to APO2L\/TRAIL","volume":"122","author":"Martinez-Lorenzo","year":"2007","journal-title":"Clin Immunol"},{"key":"10.1016\/j.imlet.2011.04.004_bib0140","doi-asserted-by":"crossref","first-page":"2272","DOI":"10.1002\/art.27501","article-title":"Liposome-bound APO2L\/TRAIL is an effective treatment in a rheumatoid arthritis model","volume":"62","author":"Martinez-Lostao","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.imlet.2011.04.004_bib0145","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1124\/jpet.109.159517","article-title":"Effect of tumor necrosis factor-related apoptosis-inducing ligand on the reduction of joint inflammation in experimental rheumatoid arthritis","volume":"332","author":"Jin","year":"2010","journal-title":"J. Pharm. Exp. Ther."},{"key":"10.1016\/j.imlet.2011.04.004_bib0150","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.4049\/jimmunol.165.5.2331","article-title":"CD7 delivers a pro-apoptotic signal during galectin-1-induced t cell Death","volume":"165","author":"Pace","year":"2000","journal-title":"J Immunol"},{"key":"10.1016\/j.imlet.2011.04.004_bib0155","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1084\/jem.185.10.1837","article-title":"Unequal death in t helper cell (Th)1 and Th2 effectors: Th1, but not Th2, effectors undergo rapid Fas\/FasL-mediated apoptosis","volume":"185","author":"Zhang","year":"1997","journal-title":"J Exp Med"},{"key":"10.1016\/j.imlet.2011.04.004_bib0160","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/sj.cdd.4401138","article-title":"Reciprocal expression of TRAIL and CD95L in Th1 and Th2 cells: role of apoptosis in T helper subset differentiation","volume":"10","author":"Zhang","year":"2003","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.imlet.2011.04.004_bib0165","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1002\/art.24329","article-title":"GATA-3 protects against severe joint inflammation and bone erosion and reduces differentiation of Th17 cells during experimental arthritis","volume":"60","author":"van Hamburg","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.imlet.2011.04.004_bib0170","doi-asserted-by":"crossref","first-page":"7238","DOI":"10.4049\/jimmunol.0903841","article-title":"Cells protect from local and systemic bone destruction in arthritis","volume":"184","author":"Zaiss","year":"2010","journal-title":"J Immunol"},{"key":"10.1016\/j.imlet.2011.04.004_bib0175","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/j.0105-2896.2009.00848.x","article-title":"CD4+ CD25+ regulatory T cells in autoimmune arthritis","volume":"233","author":"Oh","year":"2010","journal-title":"Immunol Rev"},{"key":"10.1016\/j.imlet.2011.04.004_bib0180","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1080\/03009740701482800","article-title":"Accumulation of FoxP3-expressing CD4+ CD25+ T cells with distinct chemokine receptors in synovial fluid of patients with active rheumatoid arthritis","volume":"36","author":"Jiao","year":"2007","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.imlet.2011.04.004_bib0185","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1111\/j.1365-2249.2005.02754.x","article-title":"CD4+ CD25+ T cells with the phenotypic and functional characteristics of regulatory T cells are enriched in the synovial fluid of patients with rheumatoid arthritis","volume":"140","author":"Mottonen","year":"2005","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.imlet.2011.04.004_bib0190","doi-asserted-by":"crossref","first-page":"R335","DOI":"10.1186\/ar1192","article-title":"CD25brightCD4+ regulatory T cells are enriched in inflamed joints of patients with chronic rheumatic disease","volume":"6","author":"Cao","year":"2004","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.imlet.2011.04.004_bib0195","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1084\/jem.20050085","article-title":"Coexpression of CD25 and CD27 identifies FoxP3+ regulatory T cells in inflamed synovia","volume":"201","author":"Ruprecht","year":"2005","journal-title":"J Exp Med"},{"key":"10.1016\/j.imlet.2011.04.004_bib0200","article-title":"FoxP3+ CD4+ T cells in systemic autoimmune diseases: the delicate balance between true regulatory T cells and effector Th-17 cells","author":"Abdulahad","year":"2010","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.imlet.2011.04.004_bib0205","doi-asserted-by":"crossref","first-page":"6173","DOI":"10.4049\/jimmunol.171.11.6173","article-title":"Suppression of immune induction of collagen-induced arthritis in IL-17-deficient mice","volume":"171","author":"Nakae","year":"2003","journal-title":"J Immunol"},{"key":"10.1016\/j.imlet.2011.04.004_bib0210","doi-asserted-by":"crossref","first-page":"5507","DOI":"10.4049\/jimmunol.158.11.5507","article-title":"Accelerated collagen-induced arthritis in IFN-gamma receptor-deficient mice","volume":"158","author":"Vermeire","year":"1997","journal-title":"J Immunol"},{"key":"10.1016\/j.imlet.2011.04.004_bib0215","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1186\/ar294","article-title":"IL-17 derived from juxta-articular bone and synovium contributes to joint degradation in rheumatoid arthritis","volume":"3","author":"Chabaud","year":"2001","journal-title":"Arthritis Res"},{"key":"10.1016\/j.imlet.2011.04.004_bib0220","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1136\/ard.2007.085431","article-title":"Combined blockade of granulocyte-macrophage colony stimulating factor and interleukin 17 pathways potently suppresses chronic destructive arthritis in a tumour necrosis factor alpha-independent mouse model","volume":"68","author":"Plater-Zyberk","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.imlet.2011.04.004_bib0225","doi-asserted-by":"crossref","first-page":"190","DOI":"10.4049\/jimmunol.181.1.190","article-title":"Th17 cells undergo Fas-mediated activation-induced cell death independent of IFN-{gamma}","volume":"181","author":"Zhang","year":"2008","journal-title":"J Immunol"},{"key":"10.1016\/j.imlet.2011.04.004_bib0230","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1084\/jem.191.7.1095","article-title":"Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) is an inhibitor of autoimmune inflammation and cell cycle progression","volume":"191","author":"Song","year":"2000","journal-title":"J Exp Med"},{"key":"10.1016\/j.imlet.2011.04.004_bib0235","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1172\/JCI118638","article-title":"CD4+ CD7\u2212CD28\u2212 T cells are expanded in rheumatoid arthritis and are characterized by autoreactivity","volume":"97","author":"Schmidt","year":"1996","journal-title":"J Clin Invest"}],"container-title":["Immunology Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165247811001209?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165247811001209?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,6]],"date-time":"2023-06-06T11:16:18Z","timestamp":1686050178000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165247811001209"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,8]]},"references-count":47,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,8]]}},"alternative-id":["S0165247811001209"],"URL":"https:\/\/doi.org\/10.1016\/j.imlet.2011.04.004","relation":{},"ISSN":["0165-2478"],"issn-type":[{"value":"0165-2478","type":"print"}],"subject":[],"published":{"date-parts":[[2011,8]]}}}